Creative Planning’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Creative Planning’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-400	Closed	-$1K	–	2119
2020 Q1	$1K	Buy	+400	New	+$2.97K	﹤0.01%	1855

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Creative Planning's SGMO Position: Q2 2026 in Review

Creative Planning sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 14,840 shares — an estimated $3.66K sold.

Creative Planning first reported a position in SGMO in Q3 2013 and held it in 37 quarters. The position peaked at $3.67M in Q4 2019. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Creative Planning reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Creative Planning sold 14,840 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $3.66K.
Creative Planning first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 37 quarters.
Creative Planning's SANGAMO THERAPEUTICS INC position peaked at $3.67M in Q4 2019.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.